Bioscience Journals Collection

2022年最新指标已更新

Taylor & Francis 旗下拥有2700+本国际优质期刊,包含全部主要学科领域,为研究人员与学者提供高质量的综合学术交流平台。旗下的生物学期刊组合拥有230+ 国际期刊, 超30万篇同行评议文章,涵盖分子、细胞、生理、化学、医学等多个领域,拥有AutophagyMolecular and Cellular Biology 等全球领先刊物。

Journals by Subjects

Autophagy
Impact Factor: 13.3 (2022)
Q1
Autophagy publishes research on autophagic processes, to advance understanding of the connection between autophagy and human health and disease.
View journal
Journal Title IF(2022) Quartile CiteScore(2022)
Autophagy 13.3 Q1 19.2
Artificial Cells, Nanomedicine and Biotechnology 5.8 Q1 15.9
Journal of Enzyme Inhibition and Medicinal Chemistry 5.6 Q1 9.7
Amyloid 5.5 Q1 8.6
Cell Cycle 4.3 Q2 7.7
Nucleus 3.7 Q3 6.7
Transcription 3.6 10.3
Adipocyte 3.3 Q3 4.9
Channels 3.3 Q3 5.6
Cell Adhesion & Migration 3.2 Q3 6.7
Tissue Barriers 3.1 5.7
Connective Tissue Research 2.9 Q2 6.6
Journal of Receptors and Signal Transduction 2.8 Q3 4.6
Biotechnic & Histochemistry 1.6 Q4 3.4
Autophagy Reports
Small GTPases 6.0
Journal of Mitochondria, Plastids and Endosymbiosis

Molecular and Cellular Biology
Impact Factor: 5.3 (2022)
Q2
This journal covers advancements in research around the molecular biology of all eukaryotic cells. It includes gene expression and genome organization, and studies of chronic diseases and conditions.
View journal
RNA Biology
Impact Factor: 4.1 (2022)
Q2
Journal publishing cutting-edge research into RNA including RNA sequencing, bioinformatics, structural biology, transcription and splicing.
View journal

Critical Reviews in Biotechnology
Impact Factor: 9.0 (2022)
Q1
Publishes on biotechnological techniques, including fermentation and genetic manipulation, relevant to fuel production and waste management industries.
View journal
Expert Opinion on Biological Therapy
Impact Factor: 4.6 (2022)
Q2
A MEDLINE-indexed journal dedicated to all aspects of biological therapy including gene therapy, gene transfer technologies, therapeutic peptides and proteins, vaccines and antibodies, cell-based therapies, stem cell therapies, and tissue-based therapies. This journal offers accelerated publication
View journal

Gut Microbes
Impact Factor: 12.2 (2022)
Q1
Gut Microbes publishes research on intestinal microbiota, and its role in gastrointestinal, liver, cardiac disease, cancer, and irritable and inflammatory bowel conditions.
View journal
All Life
Impact Factor: 1.2 (2022)
Focuses on life science research contributing to achieving the goals of ‘Zero Hunger,’ ‘Good Health and Well-being,’ ‘Life Below Water’ and ‘Life on Land.’
View journal

Mitochondrial DNA Part B
Impact Factor: 0.5 (2022)
Open-access research on mitochondrial DNA, particularly sequencing; rapid communications on its physical chemistry, biochemistry, metabolism and interactions.
View journal
Mitochondrial DNA Part A
Impact Factor:
Research on chemistry and biochemistry and mitochondrial DNA manipulation, proteins in mtDNA metabolism and/or interactions; cytosolic and extracellular mtDNA.
View journal
Epigenetics Reports
Impact Factor:
Publishes original research on all aspects of Epigenetics, including advances in epigenetic mechanisms and its regulation of biological and disease processes.
View journal
Impact Factor:

了解更多生物学及其他各学科高水平国际期刊,请访问 Taylor & Francis Group 旗下学术期刊网站, 欢迎相关学科研究人员向您青睐的杂志投稿。

期刊网站:www.tandfonline.com

立即投稿

Editing Services advert with pencil and envelopes background

Taylor & Francis 编辑润色服务

在准备向期刊提交稿件的时候,您需要协助吗? Taylor & Francis 编辑润色服务提供包括英语语言编辑、科学润色、翻译加编辑、稿件格式调整、相似度检查以及技术审核等,让您将时间集中在研究上。

Author Services Button

为期刊、图书作者提供的实用指南

在您准备撰写一篇国际学术论文时,一个为您提供必要指导和资源实用网站可以为您解答许多疑问!从选刊、写作、投稿、同行评审、出版等各个方面给予详细的指导,写作投稿前的必看网站!

Choose Open.

拥抱开放科学

开放获取对于作者、读者而言极具价值,开放科学让研究在更广泛的维度得到参考和使用,提升研究可见度和影响力,造福社会。您是否考虑发表开放获取文章?点击了解开放获取出版更多信息